← All Aardvark Therapeutics, INC filings

Aardvark Therapeutics, INC Form 4 insider transactions

NASDAQ
AARD
Aardvark Therapeutics, INC
Form 4: Cormorant Asset Management Reports Ownership Changes in Aardvark Therapeutics Following IPO
Cormorant Asset Management reports changes in beneficial ownership of Aardvark Therapeutics stock following the company's initial public offering.